0001209191-15-009472.txt : 20150204 0001209191-15-009472.hdr.sgml : 20150204 20150204165329 ACCESSION NUMBER: 0001209191-15-009472 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20150202 FILED AS OF DATE: 20150204 DATE AS OF CHANGE: 20150204 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: VERTEX PHARMACEUTICALS INC / MA CENTRAL INDEX KEY: 0000875320 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043039129 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6173416393 MAIL ADDRESS: STREET 1: 50 NORTHERN AVENUE CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Silva Paul M CENTRAL INDEX KEY: 0001446372 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19319 FILM NUMBER: 15576184 MAIL ADDRESS: STREET 1: C/O VERTEX PHARMACEUTICALS INCORPORATED STREET 2: 130 WAVERLY ST CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2015-02-02 0 0000875320 VERTEX PHARMACEUTICALS INC / MA VRTX 0001446372 Silva Paul M C/O VERTEX PHARMACEUTICALS INCORPORATED 50 NORTHERN AVENUE BOSTON MA 02210 0 1 0 0 SVP & Corp Controller Common Stock 2015-02-02 4 M 0 1125 37.86 A 18312 D Common Stock 2015-02-02 4 S 0 300 108.11 D 18012 D Common Stock 2015-02-02 4 S 0 668 109.89 D 17344 D Common Stock 2015-02-02 4 S 0 157 110.76 D 17187 D Common Stock 2015-02-03 4 M 0 938 38.80 A 18125 D Common Stock 2015-02-03 4 S 0 438 107.04 D 17687 D Common Stock 2015-02-03 4 S 0 300 108.16 D 17387 D Common Stock 2015-02-03 4 S 0 100 109.50 D 17287 D Common Stock 2015-02-03 4 S 0 100 111.32 D 17187 D Common Stock 169 I 401(k) Stock Option (right to buy) 37.86 2015-02-02 4 M 0 1125 0.00 D 2022-02-01 Common Stock 1125 4500 D Stock Option (right to buy) 38.80 2015-02-03 4 M 0 938 0.00 D 2021-02-02 Common Stock 938 0 D Transaction made pursuant to Mr. Silva's company approved trading plan under Rule 10b5-1. Open market sales reported on this line occurred at a weighted average price of $108.11 (range $107.94 to $108.22). Mr. Silva undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price. Open market sales reported on this line occurred at a weighted average price of $109.89 (range $109.51 to $110.42). Open market sales reported on this line occurred at a weighted average price of $110.76 (range $110.74 to $110.80). Open market sales reported on this line occurred at a weighted average price of $107.04 (range $106.77 to $107.45). Open market sales reported on this line occurred at a weighted average price of $108.16 (range $108.03 to $108.40). The option vests in 16 quarterly installments from 02/02/2012. Fully vested. Omar White, Attorney-In-Fact 2015-02-04